Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18
Clinical trial NCT04849026 · COMPLETED
Trial details
- NCT number
- NCT04849026
- Sponsor
- Whanin Pharmaceutical Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-15
- Primary completion
- 2022-08-14
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.